Both Ovobank and FIV Marbella comply with the Spanish Assisted Reproduction Law 14/2006, as well as Royal Decree-Law 09/2017 on cell and tissue bank in quality system (both transpositions to the national territory of European directives 2004/23 / EC, 2006/17 / EC and 2006/86 / EC, where the collection, donation, testing, traceability, storage and distribution of donor gametes are regulated), having obtained the authorization as a human egg bank from the Spanish health authorities.

Most of our donors are women between 18 and 34 years old with good physical and psychological health. They are selected to cover all possible physical characteristics. 100% of our donors have completed basic studies, 75% have secondary education, and of these, more than half have done or are doing some kind of further education.

All of our donors go through an initial evaluation consisting of an interview conducted by the center’s psychologist in which the psychological profile of the donor is assessed to rule out any possible hereditary psychopathologies. In addition, family and personal history for both psychological and potentially communicable diseases to descendants.

Through an in-depth interview conducted by our team of specialists, the existence of psychiatric or psychological disorders or inadequate habits is ruled out.

This is performed by the gynaecologist and consists of:

• Full gynecological revision. Ultrasound and antral follicle count, breast examination, cytology, blood pressure and heart function.
• Analysis. Full blood count, blood clotting, blood group and Rh, liver and kidney function.
• Serology. Serology screening for sexually transmitted diseases. HIV viral load is also determined by molecular techniques (RNA viral-load) to rule out recent viral infection.

The blood tests are a very important step in the selection process of Ovobank donors, to ensure their good physical and psychological condition.

• - PATHOLOGICAL ANATOMY
• - HEMOGRAM
• - BIOCHEMISTRY
• - COAGULATION
• - REAL-TIME BLOOD ANALYSIS
• - SEROLOGY

Ovobank has been carrying out the recessive mutation test (Genetic Matching Test) since 1 December 2016 on new donors. It is an innovative technique that allows us to minimize the transmission of genetic diseases to children born from our donor eggs.
This is achieved thanks to these tests:

• Allowing us to exclude candidates with autosomal recessive mutations, including cystic fibrosis, hemoglobinopathy, spinal muscular atrophy, alpha and beta thalassemia, as well as more than 30 X-linked diseases, such as Haemophilia, X-fragile, Alport syndrome, some dystrophies, etc. This means that the candidates carrying mutations related to any of these diseases will not be part of our oocyte donation program.
• In addition, if patients wish, we can perform a genetic compatibility study between the donor and the recipient` s husband, which consists of analysing the genetic information of more than 300 diseases to ensure that the donor and the patient do not share any of the recessive mutations studied thus minimizing the risk of transmission of a genetic disease to their offspring.

Although most of our donors have already been studied with the Recombine test, we can add any diagnostic study at the request of our Collaborating Centres.
Recombine, Qgenomics, Igenomics, Precongen & Bioarray.

Of all the potential donors, only a third are selected for treatment as exclusion criteria are very strict. The main goal of treatment for oocyte donation is the welfare of the donor so the medication dose is adjusted according to the hormonal study, body mass index and other features. Our donors are monitored at all times so that the treatment is not traumatic for them physically or psychologically. After the intervention they can lead a normal life, they are also monitored for 6 months after treatment.

Donation is carried out in our facilities thereby minimizing the potential risks that this treatment could entail. The operating rooms and laboratory are equipped with sterile conditions necessary for this type of activity. The extracted oocytes are immediately treated by the laboratory staff for vitrification.